STOCK TITAN
  1. Home
  2. Sec-filings
  3. clbt
  4. [144] Cellebrite DI Ltd. SEC Filing

Cellebrite (NASDAQ: CLBT) insider plans more tax-related share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) is the issuer for which Thomas E. Hogan has filed a Rule 144 notice covering ordinary shares, par value NIS 0.00001 per share, listed on Nasdaq. The shares relate to restricted share units vested under an issuer S-8 registered compensation plan.

The reporting person states an intention to sell shares on 08/25/2026 through Morgan Stanley Smith Barney LLC under a mandatory, non-discretionary sell-to-cover arrangement solely to satisfy income tax liabilities from RSU vesting. Recent activity includes open-market sales of Cellebrite ordinary shares during the past three months.

Positive

  • None.

Negative

  • None.
Shares sold 07/02/2026 103,188 ordinary shares Cellebrite DI Ltd. ordinary shares sold by Thomas E. Hogan on 07/02/2026
Proceeds 07/02/2026 $1,625,892.04 Aggregate sale price for 103,188 ordinary shares sold on 07/02/2026
Shares sold 08/12/2026 139,712 ordinary shares Cellebrite DI Ltd. ordinary shares sold by Thomas E. Hogan on 08/12/2026
Proceeds 08/12/2026 $2,149,638.19 Aggregate sale price for 139,712 ordinary shares sold on 08/12/2026
Par value per ordinary share NIS 0.00001 Par value of Cellebrite DI Ltd. ordinary shares covered by the filing
Intended sale date 08/25/2026 Date on which the reporting person intends to sell shares under the sell-to-cover arrangement
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Share Units financial
"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
S-8 Registered Plan regulatory
"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"
sell-to-cover arrangement financial
"pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes"
income tax liabilities financial
"for the purposes of satisfying income tax liabilities incurred upon vesting"

FAQ

What does the Form 144 filing for CLBT by Thomas E. Hogan disclose?
It discloses that Thomas E. Hogan intends to sell Cellebrite DI Ltd. ordinary shares on 08/25/2026 under Rule 144. The shares arise from restricted share units vested under an issuer S-8 registered compensation plan and will be sold through Morgan Stanley Smith Barney LLC.

Why are CLBT shares being sold under this Form 144 notice?
The notice states the shares will be sold on 08/25/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the sole purpose of satisfying income tax liabilities incurred upon vesting of restricted share unit awards.

What CLBT share sales has Thomas E. Hogan reported in the past 3 months?
He reported selling 103,188 ordinary shares on 07/02/2026 for $1,625,892.04, and 139,712 ordinary shares on 08/12/2026 for $2,149,638.19. Both involved Cellebrite DI Ltd. ordinary shares, par value NIS 0.00001.

What type of CLBT security is covered by this Form 144?
The filing covers ordinary shares of Cellebrite DI Ltd., with a par value of NIS 0.00001 per share. These shares are associated with restricted share units vested under the company’s S-8 registered compensation plan.

On which market are the CLBT shares in this Form 144 listed?
The ordinary shares of Cellebrite DI Ltd. referenced in the Form 144 are listed on Nasdaq, as indicated in the securities information section of the notice.

Who is the broker handling the planned CLBT share sale under this Form 144?
The planned transaction is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as disclosed in the Securities Information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR